Evidence map›Paper›PMID 37579180›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

β-lapachone regulates mammalian inositol pyrophosphate levels in an NQO1- and oxygen-dependent manner.

Verena B Eisenbeis, Danye Qiu, Oliver Gorka, Lisa Strotmann, Guizhen Liu, Isabel Prucker, Xue Bessie Su, Miranda S C Wilson, Kevin Ritter, Christoph Loenarz and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. EstablishingAnalytical chemistry · 2025
    Article
  3. Article
  4. Global profiling of N-terminal cysteine-dependent degradation mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Verena B EisenbeisFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.
Danye QiuFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.
Oliver GorkaInstitute of Neuropathology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg 79106, Germany.ORCID 0000-0002-8245-3008
Lisa StrotmannFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.ORCID 0000-0002-7571-7909
Guizhen LiuFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.ORCID 0000-0003-1748-6687
Isabel PruckerFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.
Xue Bessie SuMedical Research Council, Laboratory for Molecular Cell Biology, University College London, WC1E 6BT London, United Kingdom.
Miranda S C WilsonMedical Research Council, Laboratory for Molecular Cell Biology, University College London, WC1E 6BT London, United Kingdom.
Kevin RitterFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.ORCID 0000-0001-7900-1855
Christoph LoenarzFaculty of Chemistry and Pharmacy, Institute for Pharmaceutical Sciences, Pharmaceutical and Medicinal Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.ORCID 0000-0002-8843-2531
Olaf GroßThe Center for Integrative Biological Signaling Studies, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.
Adolfo SaiardiMedical Research Council, Laboratory for Molecular Cell Biology, University College London, WC1E 6BT London, United Kingdom.ORCID 0000-0002-4351-0081
Henning J JessenFaculty of Chemistry and Pharmacy, Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg im Breisgau 79104, Germany.ORCID 0000-0002-1025-9484
University of Freiburg · DEMRC Laboratory for Molecular Cell Biology · GB

Funding

Medical Research Council MR/T028904/1
6 · The paper itself

Abstract

Inositol pyrophosphates (PP-InsPs) are energetic signaling molecules with important functions in mammals. As their biosynthesis depends on ATP concentration, PP-InsPs are tightly connected to cellular energy homeostasis. Consequently, an increasing number of studies involve PP-InsPs in metabolic disorders, such as type 2 diabetes, aspects of tumorigenesis, and hyperphosphatemia. Research conducted in yeast suggests that the PP-InsP pathway is activated in response to reactive oxygen species (ROS). However, the precise modulation of PP-InsPs during cellular ROS signaling is unknown. Here, we report how mammalian PP-InsP levels are changing during exposure to exogenous (H

Indexed as

Diabetes Mellitus, Type 2NaphthoquinonesAdenosine TriphosphateCell Line, TumorDiphosphatesHumansHydrogen PeroxideInositolNAD(P)H Dehydrogenase (Quinone)OxygenReactive Oxygen SpeciesAdenosine Triphosphatebeta-lapachoneDiphosphatesdiphosphoric acidHydrogen PeroxideInositolNAD(P)H Dehydrogenase (Quinone)NaphthoquinonesNQO1 protein, humanOxygenReactive Oxygen Specieshypoxiainositol pyrophosphatesNQO1ROSβ-lapachone

Identifiers

PMID37579180
PMCPMC10450438
OpenAlexW4385802280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.